Cleared Traditional

K133047 - RAPIDFRET ORAL FLUID ASSAY FOR MDMA, RAPIDFRET ORAL FLUID CALIBRATORS, RAPIDFRET ORAL FLUID CONTROLS, RAPIDEASE ORAL FLU
(FDA 510(k) Clearance)

Dec 2014
Decision
447d
Days
Class 2
Risk

K133047 is an FDA 510(k) clearance for the RAPIDFRET ORAL FLUID ASSAY FOR MDMA, RAPIDFRET ORAL FLUID CALIBRATORS, RAPIDFRET ORAL FLUID CONTROLS, RAPIDEASE ORAL FLU. This device is classified as a Gas Chromatography, Methamphetamine (Class II - Special Controls, product code LAF).

Submitted by Biophor Diagnostics, Inc. (Redwood City, US). The FDA issued a Cleared decision on December 18, 2014, 447 days after receiving the submission on September 27, 2013.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.3610.

Submission Details

510(k) Number K133047 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2013
Decision Date December 18, 2014
Days to Decision 447 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LAF — Gas Chromatography, Methamphetamine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3610

Similar Devices — LAF Gas Chromatography, Methamphetamine

All 48
SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay
K203647 · Immunalysis Corporation · Dec 2021
Psychemedics Homogeneous Enzyme Immunoassay for Amphetamines in Hair
K210212 · Psychemedics Corporation · Dec 2021
Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers
K201442 · Diatron Group · Jul 2020
Rapid Tox Cup II
K170222 · American Bio Medica Corp. · Aug 2017
Immunalysis Methamphetamine Urine Enzyme Immunoassay, Immunalysis Multi-Drug Calibrators
K153693 · Immunalysis Corporation · Mar 2016
Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret Oral Fluid Methamphetamine Calibrators, Rapidfret Oral Fluid Methamphetamine Controls
K142293 · Biophor Diagnostics, Inc. · Sep 2015